Search results for: 'share case partnering 2004 221b'
- Did you mean
- share care partnering 2004 221b
- Related search terms
- partnering agreements well base 2024 2024
- partnering agreements with near therapeutic 2025 2020
- partnering agreements with real pharmaceutical 2025 2016
- partnering agreements where bristol market squibb 2017 2017
- partnering agreements wheez actavis formerly watson pharmaceutical 2025 2025
-
Manufacturing and Supply Deals in Pharmaceuticals and Biotechnology 2021-2026March 2026$3,995.00Manufacturing and Supply Deals in Pharmaceuticals and Biotechnology | Global coverage | Deal financials | Contract documents | Deal trends | Leading dealmakers | Comprehensive deal directory 2021 to 2026
Learn More -
Bioinformatics Collaboration and Licensing Deals 2019-2025November 2025$3,995.00Bioinformatics Collaboration and Licensing Deals | Global coverage | Deal financials | Contract documents | Deal trends | Leading dealmakers | Collaboration, licensing, development, and research deals |Comprehensive deal directory 2019 to 2025
Learn More -
Cancer Monoclonal Antibody Collaboration and Licensing Deals 2016-2025November 2025$3,995.00Cancer Monoclonal Antibody Collaboration and Licensing Deals | Global coverage | Deal financials | Contract documents | Deal trends | Leading dealmakers | Collaboration, licensing, development, and research deals |Comprehensive deal directory 2016 to 2025
Learn More -
Antibody Collaboration and Licensing Deals 2019-2025November 2025$3,995.00Antibody Collaboration and Licensing Deals | Global coverage | Deal financials | Contract documents | Deal trends | Leading dealmakers | Collaboration, licensing, development, and research deals |Comprehensive deal directory 2019 to 2025
Learn More -
Genomic Collaboration and Licensing Deals 2018-2025November 2025$3,995.00Genomics Collaboration and Licensing Deals | Global coverage | Deal financials | Contract documents | Deal trends | Leading dealmakers | Collaboration, licensing, development, and research deals |Comprehensive deal directory 2018 to 2025
Learn More -
Monoclonal Antibody Collaboration and Licensing Deals 2019-2025November 2025$3,995.00Monoclonal Antibody Collaboration and Licensing Deals | Global coverage | Deal financials | Contract documents | Deal trends | Leading dealmakers | Collaboration, licensing, development, and research deals |Comprehensive deal directory 2016 to 2025
Learn More -
Artificial Intelligence (AI) Collaboration and Licensing Deals in Pharma, Biotech and Diagnostics 2019-2025November 2025$3,995.00Artificial Intelligence (AI) Collaboration and Licensing Deals | Global coverage | Deal financials | Contract documents | Deal trends | Leading dealmakers | Collaboration, licensing, development, and research deals |Comprehensive deal directory 2019 to 2025
Learn More -
Autoimmune Collaboration and Licensing Deals 2016-2026April 2026$3,995.00Autoimmune Collaboration and Licensing Deals | Global coverage | Deal financials | Contract documents | Deal trends | Leading dealmakers | Collaboration, licensing, development, and research deals |Comprehensive deal directory 2016 to 2026
Learn More -
Merger and Acquisition (M&A) Deals in Pharmaceuticals, Biotechnology and Diagnostics 2021-2026March 2026$3,995.00Global coverage | Deal financials | Contract documents | Deal trends | Leading M&A dealmakers | Comprehensive deal directory 2021 to 2026
Learn More -
Infectious Vaccine Collaboration and Licensing Deals 2016-2025November 2025$3,995.00Infectious Vaccine Collaboration and Licensing Deals | Global coverage | Deal financials | Contract documents | Deal trends | Leading dealmakers | Collaboration, licensing, development, and research deals |Comprehensive deal directory 2016 to 2025
Learn More
- Category CP Reports Store Remove This Item
